| Application no. and date | 21165709.3 (espacenet) (Federated) (European Patent Register), 20150210 | | Patent/reg. no. and date | DK/EP 3889172, 20240501 | | Publication date | 20211006 | | Priority no. and date | US 201461938048 P, 20140210 | | EP pub. no. and date |
EP 3889172 20211006 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | V477094DK00 | | Inventor | LO, Kin-Ming, 6 Carol Lane
Lexington, MA 02420, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07K 14/71 (2006.01) , C07K 16/22 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) , C07K 19/00 (2006.01) | | Title | Målrettet TGF-Beta-inhibering | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
